Record:   Prev Next
作者 Godinho, Joana
書名 Stopping Tuberculosis in Central Asia : Priorities for Action
出版項 Washington : World Bank Publications, 2005
©2005
國際標準書號 9780821362778 (electronic bk.)
9780821362761
book jacket
說明 1 online resource (220 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
系列 World Bank Working Paper, No. 56 ; v.No. 56
World Bank Working Paper, No. 56
附註 Contents -- Acknowledgments -- Acronyms and Abbreviations -- Executive Summary -- Part I: Priorities for Action -- 1 Introduction -- The Global TB Epidemic -- TB in the Former Soviet Union -- TB in Prisons -- TB Control in the Former Soviet Union -- 2 Tuberculosis in Central Asia -- Epidemiology of TB in Central Asia -- TB Control in Central Asia -- 3 Main Findings and Key Actions to Stop TB in Central Asia -- Main Epidemiological Issues -- DOTS Implementation in Central Asia -- Funding of TB Control in Central Asia -- 4 The World Bank Role on TB Control -- Part II: Country Profiles -- 5 The Republic of Kazakhstan -- Main Challenges in Achieving Global TB Targets -- Profile Introduction -- TB Epidemiology -- Tuberculosis Control -- Financing TB Control -- 6 The Kyrgyz Republic -- Main Challenges in Achieving Global TB Targets -- Profile Introduction -- TB Epidemiology -- Tuberculosis Control -- Financing TB Control -- 7 The Republic of Tajikistan -- Main Challenges in Achieving Global TB Targets -- Profile Introduction -- TB Epidemiology -- Tuberculosis Control -- Financing TB Control -- 8 The Republic of Uzbekistan -- Main Challenges in Achieving Global TB Targets -- Profile Introduction -- TB Epidemiology -- Tuberculosis Control -- Financing TB Control -- References -- LIST OF TABLES -- 1. Key Global TB Epidemiological and Financial Indicators -- 2. FSU and DOTS Approaches to TB Control -- 3. General Country Data 2002 -- 4. Notification and Detection of TB in Central Asia 2002 -- 5. TB Notification and Mortality Rate in Central Asia in 2003 -- 6. HIV and TB/AIDS Cases in Central Asia -- 7. TB Notification and Mortality in Prisons in Central Asia 2003 -- 8. MDRTB in Prisons in Central Asia in 2002 (%) -- 9. TB/HIV Cases in Prisons in Central Asia 2003 -- 10. Infrastructure of TB Services in Central Asia -- 11. DOTS Strategy in Central Asia
12. DOTS Coverage in Central Asia 1998-2003 (%) -- 13. Estimated Percentage of all TB Cases Notified -- 14. TB Control in Prisons in 2002 -- 15. TB Treatment Outcome 2002 -- 16. DOTS Treatment Success 1995-1999 (%) -- 17. Public TB Spending by Country in 2002 -- 18. Gaps in TB Spending by Country 2002 -- 19. TB Costs, Indirect Costs and Rates of Return -- 20. Donor Contributions for TB Control in Central Asia (thousands) -- 21. TB Notification and Mortality Rates per 100,000 in Kazakhstan -- 22. TB Notification and Mortality among the Prison Population -- 23. Percentage of Sputum Smear Positives among all TB Cases Notified -- 24. Treatment Outcomes for New Smear-Positive Cases Treated Under DOTS -- 25. Donor Assistance to TB Control in Kazakhstan (US) -- 26. Donor Assistance to TB Control in Kazakhstan -- 27. Cost-Benefit Analysis -- 28. Direct, Indirect, and Total TB Costs in a Typical Year -- 29. Kazakhstan-SWOT Analysis -- 30. TB Notification and Mortality Rates per 100,000 -- 31. TB Notification and Mortality Rates per 100,000 Prisoners -- 32. TB Institutional Structure -- 33. TB Beds and DOTS Coverage in Kyrgyz Prisons -- 34. Treatment Outcome in New Sputum Smear Positive Pulmonary TB Patients -- 35. Treatment Outcome in Re-Treatment Cases of Pulmonary TB Cases -- 36. Treatment Outcome of New Sputum Positive TB Patients in Prisons -- 37. Public Funding of TB Control Program in the Kyrgyz Republic -- 38. Donor Funding for TB Control Programs (US) -- 39. TB Performance by Oblast and Inputs -- 40. Cost-Benefit Analysis -- 41. Direct, Indirect and Total TB Costs in a Typical Year -- 42. TB Notification and Mortality Rates in Tajikistan -- 43. TB Case Notification and Mortality among Prisoners -- 44. Percentage of Sputum Smear Positives among all TB Cases Notified -- 45. Treatment Outcome of New Smear Positive Cases in Dushanbe City (3 Cohorts)
46. Donor Funding for TB Control Programs (US thousands) -- 47. TB Performance by Oblast and Indicator -- 48. Cost-Benefit Analysis -- 49. Direct, Indirect and Total TB Costs in a Typical Year -- 50. TB Notification and Mortality Rates per 100,000 -- 51. TB Notification and Mortality Rates per 100,000 by Oblast -- 52. TB in Prisons -- 53. New Pulmonary TB Cases -- 54. Inputs for TB Control in Prisons 1998-2002 -- 55. Treatment Outcome in New Sputum Smear Positive TB Cases -- 56. Donor Assistance to TB Control (US thousands) -- 57. Donor Assistance to TB Control in Uzbekistan -- 58. Oblast Orientation by TB Budget Category, 2002-2004 -- 59. Oblast Budget Profile and TB Outcomes -- 60. TB Performance by Oblast and Indicator -- 61. Cost-Benefit Analysis -- 62. Direct, Indirect and Total TB Costs in a Typical Year -- LIST OF FIGURES -- 1. TB Notification Rates in Kazakhstan, Kyrgyz Republic, Tajikistan, and Uzbekistan -- 2. HIV Infections Newly Diagnosed per Million Population -- 3. TB Notification Rates in Kazakhstan, Kyrgyz Republic, Tajikistan, and Uzbekistan 1990-2002 -- 4. TB Mortality Rate in Central Asia per 100,000 Population 1990-2003 -- 5. Estimated Number of Lives Saved by DOTS in Kazakhstan 1999-2001 -- 6. Increase of TB/HIV Dual Infection among 20 years-old in Kazakhstan -- 7. Organizational Chart of the Kyrgyz National TB Program -- 8. TB Hospital Performance by Country 2002 -- 9. TB Public Spending in Central Asia 2002 -- 10. Donor Contributions by Country, 2002 -- 11. Salaries and Drugs in National TB Programs -- 12. TB Costs as Percentage of GDP by Country -- 13. TB Performance Indicators by Country -- 14. TB Incidence Rates by Country or Region, 2002 -- 15. Population Covered by DOTS 2002 -- 16. Percentage TB Notification per Age Group in 2002 -- 17. TB Notification and Mortality Rate per 100,000
18. Estimated Number of Lives Saved by DOTS in Kazakhstan 1999-2001 -- 19. TB Beds per 100,000 Persons by Oblast in 2003 -- 20. Turnover Rate and Bed Occupancy Rate in Kazak TB Hospitals in 2003 -- 21. TB Public Spending in the Economy in 2002 -- 22. Cost per TB Patient by Oblast in 2002 -- 23. Distribution of TB Contributions by Donor 2002-2007 -- 24. TB Budget Structure in 2002 -- 25. Contribution for TB Control by Account in 2002 -- 26. Distribution of TB Resources by Oblast in 2002 -- 27. TB Spending per Capita by Oblast in 2002 in US -- 28. Participation of TB Budget Accounts by Oblast in 2002 -- 29. TB Per Capita Spending and Cure Rates in 2003 -- 30. TB Doctors and Cure Rates in 2003 -- 31. TB Drug Spending and Cure Rates by Oblast in 2003 -- 32. TB Beds and Cure Rates in 2003 -- 33. TB Facilities and Cure Rates in 2003 -- 34. TB Notification by Age and Gender in 2002 -- 35. TB Notification and Mortality Rates per 100,000 -- 36. Organizational Chart of the Kyrgyz National TB Program -- 37. Supply of TB Beds by Republican Institution, 2003 -- 38. Republican TB Institutions Performance, 2003 -- 39. Expected Public TB Spending, 2001-2008 (in Million Soms and US) -- 40. Expected Public TB Expenditures per Capita, 2001-2008 (in Soms and US) -- 41. Expected Public TB Spending as a Percentage of GDP and Health Care, 2001-2008 -- 42. Participation of TB Budget in Government Expenditures, 2001-2008 -- 43. Distribution of Donor Assistance 2002-2008 -- 44. TB Expenditures per Capita by Oblast 2002-2003 (US) -- 45. TB Cost per Patient by Oblast 2003 (US) -- 46. TB Budget Structure by Category 2002-2003 -- 47. TB Drug and Food Costs per Patient-Day by Oblast in 2003 (US) -- 48. Drug and Food Participation in Oblast TB Budgets, 2001-2003 -- 49. Share of Republican TB Hospitals in Total Expenditures 2001-2003
50. Structure of Republican TB Hospital Expenditures by Category, 2001-2003 -- 51. Cost per Bed by TB Hospital 2003 -- 52. Unitary Costs of TB Treatment-Related Components, 2003 -- 53. TB Cases and Budget per Capita, 2002 -- 54. TB Notification Rate and Budget per Capita, 2001-2002 -- 55. Growth in TB Budget per Capita and Cure Rates 2001-2002 -- 56. Growth in TB Budget per Capita and Case Fatality Rates, 2001-2002 -- 57. Growth in TB Doctors per 100 Cases and the Cure Rate, 2001-2002 -- 58. Spending on TB Drugs and Cure Rates, 2001-2002 -- 59. Growth in TB Beds per 100 Cases and Cure Rates, 2001-2002 -- 60. TB Notification and Mortality Rates 1998-2003 -- 61. Age Specific TB Notification Rate by Gender, 2002 -- 62. TB Epidemiological Situation in Prisons -- 63. TB Cases per Bed in Prisons, 1998-2002 -- 64. TB Hospital Performance, 2003 -- 65. TB Public Spending per Capita and as a Share of GDP, 2002-2003 -- 66. Daily Costs of TB Inputs 2003 -- 67. Structure of International Assistance by Donor 2002-2005 -- 68. Composition of TB Budget by Program 2002-2003 -- 69. Distribution of TB by Budget Category 2002-2003 -- 70. Oblast Participation in the Public TB Budget 2002-2003 -- 71. TB Spending per Capita by Oblast 2002-2003 -- 72. TB Spending per Capita and Mortality Rates, 2003 -- 73. TB Beds and Death Rates -- 74. TB Drugs and Death Rates -- 75. TB Notification Rate and Mortality Rate per 100,000 Population -- 76. Percentage TB Notification per Age Group in 2003 -- 77. Newly-Registered HIV/AIDS Cases in Uzbekistan -- 78. TB Beds per 100,000 Population and per 1,000 New Cases, 1998-2003 -- 79. TB Beds per 10,000 Habitants per Oblast, 2002 -- 80. TB Hospital Performance in Uzbekistan 2002 -- 81. Outcomes of DOTS in New SS (+) Cases in Karakalpakstan 1998-2002 -- 82. TB Expenditures as a Percentage of GDP, 2002-2004
83. Cost per Day per TB Patient, New Case, and Bed, 2002
Tuberculosis is still a significant health and economic problem in Central Asia, despite some recent progress that may be due to improvements of the overall economic situation in these countries, and partial adoption of the DOTS Strategy recommended by WHO. Over 50,000 new cases have been detected in 2003 and over 7,000 people died due to TB in the four countries studied. This study has confirmed that it is highly unlikely that these Central Asian republics will succeed in achieving the global targets for tuberculosis control in the short term, particularly with regard to case detection. In the meantime, the epidemic continues to have a serious epidemiological impact and affects the economies of these countries, which incur productivity losses and indirect costs that are estimated to range from 0.5 to 0.8 percent of GDP annually. Stopping Tuberculosis in Central Asia reviews the epidemiological situation, control efforts, and financing of tuberculosis programs in Kazakhstan, Kyrgyz Republic, Tajikistan, and Uzbekistan. It was based on a review of existing statistics and reports, and on consultation with key stakeholders-Governments, NGOs, and donors in Central Asia. This work contributes an agenda for action to address the impending epidemiological crisis that has been posed by the sudden increase in cases of HIV/AIDS infection combined with a prevalent epidemic of TB
Description based on publisher supplied metadata and other sources
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2020. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries
鏈接 Print version: Godinho, Joana Stopping Tuberculosis in Central Asia : Priorities for Action Washington : World Bank Publications,c2005 9780821362761
主題 Tuberculosis -- Asia, Central.;Tuberculosis
Electronic books
Alt Author Veen, Jaap
Cercone, James
Pacheco, Jose
Dara, Masoud
Record:   Prev Next